Trial Profile
Rheumatoid Arthritis Ultrasound Response to Methotrexate
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Nordic Group
- 05 Aug 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2019).
- 05 Aug 2019 Planned End Date changed from 31 May 2020 to 31 Aug 2020.
- 05 Aug 2019 Planned primary completion date changed from 31 May 2020 to 31 Aug 2020.